HT-1376 In Vitro High Content Screening (HCS) Assay
CAT#: ITS-1022-YF2931
Target Cell Organism: Human
Target Cell Name: HT-1376
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide HT-1376-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HT-1376
Target Cell Organism
Human
Target Cell Background
HT-1376 is an epithelial-like cell isolated from the urinary bladder of a White, 58-year-old, female with carcinoma. This cell line was deposited by S Rasheed and can be used for immuno-oncology research.
Related Diseases
Urinary Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Short Description
HT-1376-cell based In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays